SYNAESTHETIC THEATRE
AI Summary
Synesthetic Theatre is a nonprofit organization dedicated to exposing the public to the arts through theatrical workshops and performances. With an operating budget of $4.9K and total revenue of $5.5K for the 2025 filing year, the organization relies heavily on a single funder, which contributes $320K, representing a significant portion of its revenue. For more information, please contact them at [email protected].
Mission Statement
TO EXPOSE THE PUBLIC TO THE ARTS AND CULTIVATE AND HOLD THEATRICAL WORKSHOPS FOR THE PUBLIC.
Cause Areas
1
Theater
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Funder
Total Funding
Funding Share
DISTRACTED GLOBE FOUNDATION
NEW YORK, NY, US
$25K
8%
Frequently Asked Questions
What is SYNAESTHETIC THEATRE’s budget?
In 2025, SYNAESTHETIC THEATRE reported an annual operating budget of around $4,933. More detailed financial information is available to registered users.
What causes does SYNAESTHETIC THEATRE support?
SYNAESTHETIC THEATRE supports work in Theater.
Where does SYNAESTHETIC THEATRE operate?
SYNAESTHETIC THEATRE is headquartered in Brooklyn, NY.
Who funded SYNAESTHETIC THEATRE recently?
In 2021, SYNAESTHETIC THEATRE received grants from DISTRACTED GLOBE FOUNDATION. More information on this organization’s funders is available to registered users.
What is the largest grant SYNAESTHETIC THEATRE received in 2021?
The largest grant to SYNAESTHETIC THEATRE in 2021 exceeds $25 thousand.